U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class
Concept
Record UNII
ZT3VR2T6GY
Record Status FAILED
Record Version
  • Download
Name Type Language
STP-705
Preferred Name English
COTSIRANIB
Common Name English
STP705 (small interfering RNA (siRNA) therapeutic directed against transforming growth factor-beta 1 (TGF-beta 1) and cyclo-oxygenase-2 (COX-2))
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 580717
Created by admin on Wed Apr 02 07:27:43 GMT 2025 , Edited by admin on Wed Apr 02 07:27:43 GMT 2025
FDA ORPHAN DRUG 614817
Created by admin on Wed Apr 02 07:27:43 GMT 2025 , Edited by admin on Wed Apr 02 07:27:43 GMT 2025
Code System Code Type Description
FDA UNII
ZT3VR2T6GY
Created by admin on Wed Apr 02 07:27:43 GMT 2025 , Edited by admin on Wed Apr 02 07:27:43 GMT 2025
PRIMARY
NCI_THESAURUS
C175941
Created by admin on Wed Apr 02 07:27:43 GMT 2025 , Edited by admin on Wed Apr 02 07:27:43 GMT 2025
PRIMARY
Related Record Type Details
HUMAN TRANSFORMING GROWTH FACTOR .BETA.-1
TARGET->INHIBITOR OF EXPRESSION
COX-2
TARGET->INHIBITOR OF EXPRESSION
Definition References
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966